日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Orizuru and Peptigrowth Develop Growth Factor Peptides
Orizuru Therapeutics Inc. and Peptigrowth Inc. are pleased to announce that they…
AlphaMeld Corporation Expands Collaboration with Kyowa Kirin
AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI),…
Medteria Raises 100 Million Yen in Funding – A Communication Cloud for Medical Professionals and Medical Students Used by 40,000 Users
Medteria Inc., provider of the "Medteria" communications cloud for healthcare professionals and…
Spine Chronicle Japan Inc. Secures 135 Million Yen in Series A Funding
Advancing Minimally Invasive Treatments for Osteoporotic Vertebral Fractures Spine Chronicle Japan Co.,…
Tsunagari Pharmacy starts collaboration with online medical treatment service Clinic Fore
Pharmashift Inc. is pleased to announce that its "Tsunagari Pharmacy" has partnered…
Transforming Philippine Healthcare: The 2025 Philippine Hospital & Healthcare Digitalization Summit
As the world embraces the next wave of digital transformation, the Philippines…
Guardant Health & ConcertAI Launch Data Service for Cancer R&D
Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading…
CAC launches telecommuting AI “Mamorimo” – Improving telecommuting security and expanding the scope of work that can be contracted
CAC Corporation, a company working to bring about digital innovation in society…
Latest Article
English